Cresco Labs Inc.
CRLBF
$0.76
$0.00-0.40%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.73% | 1.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.73% | 1.75% | |||
| Cost of Revenue | 6.45% | -7.76% | |||
| Gross Profit | -7.45% | 12.63% | |||
| SG&A Expenses | -4.28% | -2.56% | |||
| Depreciation & Amortization | 27.51% | -14.27% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.85% | -5.99% | |||
| Operating Income | -20.52% | 86.97% | |||
| Income Before Tax | -468.11% | 398.91% | |||
| Income Tax Expenses | -28.67% | 16.21% | |||
| Earnings from Continuing Operations | -58.12% | 8.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 301.31% | -404.36% | |||
| Net Income | -4.41% | -13.18% | |||
| EBIT | -20.52% | 86.97% | |||
| EBITDA | -12.09% | 41.90% | |||
| EPS Basic | -4.12% | -11.89% | |||
| Normalized Basic EPS | 103.23% | 1,450.00% | |||
| EPS Diluted | -4.12% | -11.89% | |||
| Normalized Diluted EPS | 103.23% | 1,450.00% | |||
| Average Basic Shares Outstanding | 0.33% | 1.17% | |||
| Average Diluted Shares Outstanding | 0.33% | 1.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||